ArticleNPJ precision oncology2025

Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization.

Kohei Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.